• 1
    Anderson RM & May RM (1992) Infectious Diseases of Humans. Oxford University Press, Oxford.
  • 2
    Austin DJ, Kristinsson KG, Anderson RM (1999) The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proceedings of the National Academy of Sciences of the United States of America96,11521156.
  • 3
    Barnes EH & Dobson RJ (1990) Population-dynamics of Trichostrongylus colubriformis in sheep – a computer model to simulate grazing systems and the evolution of anthelmintic resistance. International Journal for Parasitology 20 , 823831.
  • 4
    Barnes EH, Dobson RJ, Barger IA (1995) Worm control and anthelmintic resistance: adventures with a model. Parasitology Today 11 , 5663.
  • 5
    Bonhoeffer S, Lipsitch M, Levin BR (1997) Evaluating treatment protocols to prevent antibiotic resistance. Proceedings of the National Academy of Sciences of the United States of America94,1210612111.
  • 6
    Cross AP & Singer B (1991) Modelling the development of resistance of Plasmodium falciparum to anti-malarial drugs. Transactions of the Royal Society for Tropical Medicine and Hygiene 85 , 349354.
  • 7
    Curtis CF & Otoo LN (1986) A simple model of the build-up of resistance to mixtures of antimalarial drugs. Transactions of the Royal Society for Tropical Medicine and Hygiene 80 , 889892.
  • 8
    Dye C & Williams BG (1997) Multigenic drug resistance among inbred malaria parasites. Proceedings of the Royal Society of London264,6167.
  • 9
    Echevarria FAM, Gettinby G, Hazelwood S (1993) Model predictions for anthelmintic resistance amongst Haemonchus contortus populations in southern Brazil. Veterinary Parasitology 47 , 315325.
  • 10
    Falconer DS & Mackay TFC (1996) Introduction to Quantitative Genetics, 4th edn. Longman, Harlow.
  • 11
    Hartl DL & Clark AG (1997) Principles of Population Genetics. 3rd edn. Sinauer Associates, Sunderland, MA, USA.
  • 12
    Hastings IM (1997) A model for the origins and spread of drug resistant malaria. Parasitology 115 , 133141.DOI: 10.1017/s0031182097001261
  • 13
    Hastings IM & D'Alessandro U (2000) Modelling a predictable disaster: the rise and spread of drug-resistant malaria. Parasitology Today 16 , 340347.DOI: 10.1016/s0169-4758(00)01707-5
  • 14
    Hastings IM, Watkins WM, White NJ (2002) The evolution of drug resistant malaria; the role of drug elimination half-life. Philosophical Transactions of the Royal Society, in press.
  • 15
    Koella JC (1998) Costs and benefits of resistance against antimalarial drugs. Parasitology Today 14 , 360364.
  • 16
    Le Jambre LF, Dobson RJ, Lenane IJ, Barnes EH (1999) Selection for anthelmintic resistance by macrocyclic lactones in Haemonchus contortus. International Journal for Parasitology 29 , 11011111.DOI: 10.1016/s0020-7519(99)00074-0
  • 17
    Levin BR & Anderson RM (1999) The population biology of anti-infective chemotherapy and the evolution of drug resistance: more questions than answers. In: Evolution in Health and Disease (ed. SC Stearns). Oxford University Press, Oxford, pp. 125–137.
  • 18
    Lipsitch M & Levin BR (1997) The population dynamics of antimicrobial chemotherapy. Antimicrobial Agents and Chemotherapy 41 , 363373.
  • 19
    Looareesuwan S, Viravan C, Webster HK, Kyle DE, Canfield CJ (1996) Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. American Journal of Tropical Medicine and Hygiene 54 , 6266.
  • 20
    Marsh VM, Mutemi WM, Muturi J et al. (1999) Changing home treatment of childhood fevers by training shop keepers in rural Kenya. Tropical Medicine and International Health 4 , 383389.
  • 21
    Maynard-Smith J (1998) Evolutionary Genetics, 2nd edn. Oxford University Press, Oxford.
  • 22
    Peters W (1984) Use of drug combinations. In: Antimalarial Drugs, Vol. 2 (eds W Peters & WHG Richards) Springer Verlag, Berlin, pp. 499–509.
  • 23
    Peters W (1998) Drug resistance in malaria parasites of animals and man. Advances in Parasitology 41 , 162.
  • 24
    Plaisier AP, Stolk WA, Van Oortmarssen GJ, Habbema JDF (2000) Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection. Parasitology Today 16 , 298302.DOI: 10.1016/s0169-4758(00)01691-4
  • 25
    Plowe CV, Cortese JF, Djimde A et al. (1997) Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. Journal of Infectious Diseases 176 , 15901596.
  • 26
    Sergent E & Sergent E (1921) Etude experimental du paludisme. Paludisme des oiseaux (Plasmodium relictum). Bulletin de la Societe de Pathologie Exotique 14 , 7278.
  • 27
    Smith G (1990) A mathematical-model for the evolution of anthelmintic resistance in a direct life-cycle nematode parasite. International Journal for Parasitology 20 , 913921.
  • 28
    Su XZ, Kirkman LA, Fujioka H, Wellems TE (1997) Complex polymorphisms in an ˜330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell 91 , 593603.
  • 29
    Trape JF, Pison G, Preziosi MP et al. (1998) Impact of chloroquine resistance on malaria mortality. Comptes Rendus de L’ Academie Des Sciences Serie Iii-Sciences de la Vie-Life Sciences 321 , 689697.
  • 30
    Watkins WM & Mosobo M (1993) Treatment of Plasmodium falciparum malaria with pyrimethamine-sulphadoxine: selective pressure for resistance is a function of long half-life. Transactions of the Royal Society of Tropical Medicine and Hygiene 87 , 7578.
  • 31
    White NJ (1999) Antimalarial drug resistance and combination chemotherapy. Philosophical Transactions of the Royal Society 354 , 739749.
  • 32
    World Health Organization (2000) Overcoming Antimicrobial Resistance: World Health Organization Report on Infectious Diseases 2000. WHO, Geneva.